Autoimmunity and oxidatively modified autoantigens.

[1]  R. H. Scofield,et al.  Improving the solubility and pharmacological efficacy of curcumin by heat treatment. , 2007, Assay and drug development technologies.

[2]  R. H. Scofield,et al.  Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification--an in vitro study. , 2007, Journal of ethnopharmacology.

[3]  K. Hensley,et al.  Oxidatively modified autoantigens in autoimmune diseases. , 2006, Free radical biology & medicine.

[4]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[5]  R. H. Scofield,et al.  Lipid peroxidation in systemic lupus erythematosus. , 2006, Indian journal of experimental biology.

[6]  R. H. Scofield,et al.  In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants. , 2005, Journal of immunological methods.

[7]  Paul J Thornalley,et al.  Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes , 2005, Diabetologia.

[8]  M. McClain,et al.  Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. , 2005, Free radical biology & medicine.

[9]  E. Matsuura,et al.  Are Oxidized LDL/β2-glycoprotein I Complexes Pathogenic Antigens in Autoimmune-mediated Atherosclerosis? , 2004, Clinical & developmental immunology.

[10]  H. C. Mehta,et al.  Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[11]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[12]  R. H. Scofield,et al.  Free radical mediated peroxidative damage in systemic lupus erythematosus. , 2003, Life sciences.

[13]  L. Klassen,et al.  Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. , 2002, Alcoholism, clinical and experimental research.

[14]  P. Lipsky,et al.  Autoantibodies as predictors of disease. , 2001, The Journal of clinical investigation.

[15]  M. Shlomchik,et al.  From T to B and back again: positive feedback in systemic autoimmune disease , 2001, Nature Reviews Immunology.

[16]  M. Allison,et al.  Enhanced immunogenicity of aldehyde‐bearing antigens: a possible link between innate and adaptive immunity , 2000, European journal of immunology.

[17]  I. Mackay,et al.  Molecular mimicry: a critical look at exemplary instances in human diseases , 2000, Cellular and Molecular Life Sciences CMLS.

[18]  D. Blake,et al.  Inflammatory mediators, free radicals and gene transcription , 2000 .

[19]  C. Evans,et al.  Free Radicals and Inflammation , 2000, Progress in Inflammation Research.

[20]  U. Baber,et al.  Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. , 1999, Arthritis and rheumatism.

[21]  T. Lehtimäki,et al.  Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  L. Szweda,et al.  Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. , 1998, Biochemistry.

[23]  J. Harley,et al.  Rheumatoid hyperviscosity: analysis of a patient with intermediate complexes that block other autoantibodies and a review of the literature. , 1998, Seminars in arthritis and rheumatism.

[24]  G. Boyd.  An evolution‐based hypothesis on the origin and mechanisms of autoimmune disease , 1997, Immunology and cell biology.

[25]  J. Harley,et al.  Genes for murine Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures and are unlinked on mouse chromosome 6. , 1996, Gene.

[26]  J. Harley,et al.  Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. , 1996, Journal of immunology.

[27]  N. Fujimoto,et al.  Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[28]  J. Harley,et al.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity , 1995, The Journal of experimental medicine.

[29]  W. Craig.  Autoantibodies against oxidized low density lipoprotein: A review of clinical findings and assay methodology , 1995, Journal of clinical laboratory analysis.

[30]  G. Bellomo,et al.  LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  T. Lindahl.  Instability and decay of the primary structure of DNA , 1993, Nature.

[32]  P H Plotz,et al.  The role of autoantibodies in autoimmune disease. , 1993, Annual review of immunology.

[33]  C. Weyand,et al.  The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis , 1992, Annals of Internal Medicine.

[34]  C. Cross,et al.  Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. , 1992, The Biochemical journal.

[35]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[36]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.

[37]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[38]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[39]  Roy L. Walford,et al.  Free radicals, aging, and degenerative diseases , 1986 .

[40]  P. Medawar,et al.  Quantitative Studies on Tissue Transplantation Immunity. III. Actively Acquired Tolerance , 1956, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.